Anna Leijon AB
ActiveKey figures
Key figures
2025/26Summary: Anna Leijon AB
What kind of company is it?
Anna Leijon AB (org. no. 559112-7013) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Vaxholm. Industry according to Statistics Sweden: other general medical practice activities (SNI 86212).
How is the company doing financially?
Net sales in financial year 2026 were 562 000 kr, down 62,8 % on the previous year (1 511 000 kr). From 2019 to 2026, net sales grew by an average of 2,5 % per year. Net profit for 2026 was 295 970 kr (52,7 % of net sales). The company was profitable in all 8 reported financial years. Employees in financial year 2023: 1. Net sales per employee were 1 354 000 kr. At the end of financial year 2026, total assets were 4 016 991 kr and equity 1 977 275 kr (equity ratio 49,2 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2019–2026
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Sales revenue | 1 448 900 | 1 354 000 | 1 358 000 | 1 511 000 | 562 000 |
| Profit for the reporting year | 834 070 | 801 745 | 819 338 | 906 363 | 295 970 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 3 004 023 | 4 212 384 | 4 572 881 | 4 356 900 | 4 016 991 |
| Total liabilities | 1 591 163 | 1 997 779 | 1 797 939 | 2 024 595 | 2 039 716 |
| Total equity | 1 412 860 | 2 214 605 | 2 774 942 | 2 332 305 | 1 977 275 |
| Employees | 1 | 1 | — | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.